Page last updated: 2024-08-22

lutetium and Hormone-Dependent Neoplasms

lutetium has been researched along with Hormone-Dependent Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerman, OC; Frielink, C; Goldenberg, DM; Lütje, S; McBride, WJ; Oyen, WJ; Sharkey, RM; van Rij, CM	1

Other Studies

1 other study(ies) available for lutetium and Hormone-Dependent Neoplasms

Article	Year
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:8 Topics: Animals; Antibodies, Bispecific; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Humans; Immunotoxins; Lutetium; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Oligopeptides; Prostatic Neoplasms, Castration-Resistant; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Xenograft Model Antitumor Assays	2014

Article

Year

Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide.

Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:8

Topics: Animals; Antibodies, Bispecific; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Humans; Immunotoxins; Lutetium; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Oligopeptides; Prostatic Neoplasms, Castration-Resistant; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Xenograft Model Antitumor Assays

2014